JP2025501731A5 - - Google Patents
Info
- Publication number
- JP2025501731A5 JP2025501731A5 JP2024536420A JP2024536420A JP2025501731A5 JP 2025501731 A5 JP2025501731 A5 JP 2025501731A5 JP 2024536420 A JP2024536420 A JP 2024536420A JP 2024536420 A JP2024536420 A JP 2024536420A JP 2025501731 A5 JP2025501731 A5 JP 2025501731A5
- Authority
- JP
- Japan
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163291639P | 2021-12-20 | 2021-12-20 | |
| US63/291,639 | 2021-12-20 | ||
| US202263354627P | 2022-06-22 | 2022-06-22 | |
| US63/354,627 | 2022-06-22 | ||
| PCT/US2022/053209 WO2023121975A1 (en) | 2021-12-20 | 2022-12-16 | Ionizable amine lipids and lipid nanoparticles |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2025501731A JP2025501731A (ja) | 2025-01-23 |
| JPWO2023121975A5 JPWO2023121975A5 (https=) | 2025-12-23 |
| JP2025501731A5 true JP2025501731A5 (https=) | 2025-12-23 |
Family
ID=85157159
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024536420A Pending JP2025501731A (ja) | 2021-12-20 | 2022-12-16 | イオン化可能なアミン脂質及び脂質ナノ粒子 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20240335385A1 (https=) |
| EP (1) | EP4452935A1 (https=) |
| JP (1) | JP2025501731A (https=) |
| AU (1) | AU2022418511A1 (https=) |
| CA (1) | CA3241488A1 (https=) |
| WO (1) | WO2023121975A1 (https=) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US12569438B2 (en) | 2019-07-29 | 2026-03-10 | Georgia Tech Research Corporation | Nanomaterials containing constrained lipids and uses thereof |
| US12435035B2 (en) | 2020-01-09 | 2025-10-07 | Guide Therapeutics, Llc | Nanomaterials |
| IL303845A (en) | 2021-01-20 | 2023-08-01 | Beam Therapeutics Inc | Nanomaterials include a degradable property |
| KR20230131863A (ko) | 2021-01-20 | 2023-09-14 | 빔 테라퓨틱스, 인크. | 나노물질 |
| US20260035338A1 (en) * | 2022-10-13 | 2026-02-05 | Shenzhen Shenxin Biotechnology Co., Ltd. | Amino lipid compound and lipid nanoparticle for delivering bioactive ingredient |
| WO2025189064A1 (en) | 2024-03-08 | 2025-09-12 | Genzyme Corporation | Lipid nanoparticles |
| WO2026003582A2 (en) | 2024-06-27 | 2026-01-02 | Axelyf ehf. | Lipids and lipid nanoparticles |
| WO2026030375A2 (en) | 2024-07-30 | 2026-02-05 | Genzyme Corporation | Lipid nanoparticles and methods of manufacture and use thereof |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20030083272A1 (en) | 1997-09-19 | 2003-05-01 | Lahive & Cockfield, Llp | Sense mrna therapy |
| AU2009238175C1 (en) | 2008-04-15 | 2023-11-30 | Arbutus Biopharma Corporation | Novel lipid formulations for nucleic acid delivery |
| SG186085A1 (en) * | 2010-06-03 | 2013-01-30 | Alnylam Pharmaceuticals Inc | Biodegradable lipids for the delivery of active agents |
| EP2788006B1 (en) * | 2011-12-07 | 2026-01-07 | Alnylam Pharmaceuticals, Inc. | Biodegradable lipids for the delivery of active agents |
| US20150165054A1 (en) | 2013-12-12 | 2015-06-18 | President And Fellows Of Harvard College | Methods for correcting caspase-9 point mutations |
| EP4019506A1 (en) * | 2013-12-19 | 2022-06-29 | Novartis AG | Lipids and lipid compositions for the delivery of active agents |
| EP4286012A3 (en) | 2015-09-17 | 2024-05-29 | ModernaTX, Inc. | Compounds and compositions for intracellular delivery of therapeutic agents |
| JP7109784B2 (ja) | 2015-10-23 | 2022-08-01 | プレジデント アンド フェローズ オブ ハーバード カレッジ | 遺伝子編集のための進化したＣａｓ９蛋白質 |
| KR102547316B1 (ko) | 2016-08-03 | 2023-06-23 | 프레지던트 앤드 펠로우즈 오브 하바드 칼리지 | 아데노신 핵염기 편집제 및 그의 용도 |
| MX2020006843A (es) * | 2017-12-27 | 2020-09-03 | Takeda Pharmaceuticals Co | Nanoparticula de lipido que contiene acido nucleico y uso de la misma. |
| KR20210139265A (ko) | 2019-02-13 | 2021-11-22 | 빔 테라퓨틱스, 인크. | 표적 서열에서 핵염기를 변형하기 위한 아데노신 데아미나제 염기 편집기 및 이의 사용 방법 |
| WO2020219876A1 (en) * | 2019-04-25 | 2020-10-29 | Intellia Therapeutics, Inc. | Ionizable amine lipids and lipid nanoparticles |
| WO2020246581A1 (ja) * | 2019-06-07 | 2020-12-10 | 富士フイルム株式会社 | 脂質組成物 |
-
2022
- 2022-12-16 CA CA3241488A patent/CA3241488A1/en active Pending
- 2022-12-16 AU AU2022418511A patent/AU2022418511A1/en active Pending
- 2022-12-16 WO PCT/US2022/053209 patent/WO2023121975A1/en not_active Ceased
- 2022-12-16 JP JP2024536420A patent/JP2025501731A/ja active Pending
- 2022-12-16 EP EP22851198.6A patent/EP4452935A1/en active Pending
-
2024
- 2024-06-18 US US18/746,810 patent/US20240335385A1/en active Pending